The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 18, 2025

Filed:

Aug. 20, 2019
Applicant:

Bessor Pharma, Llc, Framingham, MA (US);

Inventors:

Barry A. Berkowitz, Framingham, MA (US);

Anthony G. Barrett, Rio de Janeiro, BR;

Daniel Elliott, Basel, CH;

Assignee:

Bessor Pharma, LLC, Framingham, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 311/78 (2006.01); A61K 31/05 (2006.01); A61K 31/352 (2006.01); C07C 37/50 (2006.01); C07C 37/56 (2006.01); C07C 39/23 (2006.01); C07D 319/08 (2006.01); C07D 493/04 (2006.01);
U.S. Cl.
CPC ...
C07D 311/78 (2013.01); A61K 31/05 (2013.01); A61K 31/352 (2013.01); C07C 37/50 (2013.01); C07C 37/56 (2013.01); C07C 39/23 (2013.01); C07D 319/08 (2013.01); C07D 493/04 (2013.01); C07C 2601/16 (2017.05);
Abstract

The use of a medicament as a single agent, binary agent, or other combination comprising of substantially pure novel cannabinoids 1 and 2, optionally admixed with one or more known and novel cannabinoids and other known naturally occurring and synthetic tetracyclic 2A and tricyclic 1A cannabinoids for the prevention, treatment or cure of inflammatory mediated diseases or inflammatory mediated pathological conditions, anorexia, arthritis, cancer, pain, glaucoma, migraine, persistent muscle spasms, seizures (epileptic seizures), severe nausea, PTSD, autism spectrum disorder, drug abuse, insomnia, or any other chronic or persistent medical symptom.


Find Patent Forward Citations

Loading…